Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
J Clin Med ; 10(6)2021 Mar 15.
Article in English | MEDLINE | ID: mdl-33804106

ABSTRACT

Clinical and electroencephalogram (EEG) features in frontal lobe epilepsy (FLE) vary considerably among patients, making the diagnosis a challenge. The objective of this study was to describe interictal and ictal EEG activity, identifying variables that could help to differentiate and diagnose frontal lobe epilepsy cases. A prospective cross-sectional study from patients with frontal interictal epileptiform discharges (IED) referred to the Vall d'Hebron University Hospital (Barcelona, Spain) after a clinical event compatible with epileptic seizures was designed. The interictal and ictal activity were analyzed to provide a detailed EEG description of the cases, using different statistical analyses. The morphological seizure pattern at the ictal onset remained globally unchanged over time in seizures arising from the frontal lobe for each patient. Isolated sharp waves were the most frequent waveforms in the expression of IED. Frontal lobe seizures are frequently short and sometimes appear grouped in clusters within the same recording. Often the ictal expression of the electrical activity in frontal lobe seizure is subtle and challenging to interpret. A description of the main findings is summarized to identify seizures arising from the frontal lobe and avoid false negatives findings in EEG interpretations.

2.
Rev. neurol. (Ed. impr.) ; 64(2): 49-54, 16 ene., 2017. tab, graf
Article in Spanish | IBECS | ID: ibc-159425

ABSTRACT

Introducción. Las epilepsias generalizadas idiopáticas (EGI) son un conjunto de síndromes electroclínicos con distintos fenotipos. Nuestro objetivo es analizar dichos fenotipos en pacientes mayores de 16 años. Pacientes y métodos. Analizamos retrospectivamente una serie de pacientes con EGI. Los clasificamos en epilepsia de ausencias infantil (EAI), epilepsia de ausencias juvenil (EAJ), epilepsia mioclónica juvenil (EMJ), epilepsia con crisis tonicoclónicas sólo (ECTC), epilepsia con ausencias y mioclonías palpebrales (EAM) y epilepsia fotogénica pura (EF). Resultados. Incluimos 308 pacientes, mayoritariamente mujeres (56,8%). La EMJ fue más prevalente (40,9%), seguida de la ECTC (30%), la EAJ (10%), la EAM (8,7%), la EAI (7,7%) y la EF (1,6%). Los tipos de crisis que presentaron más pacientes fueron las tonicoclónicas (89,6%), las mioclónicas (45,4%), las ausencias (31,4%), las crisis reflejas (13,3%), las mioclonías palpebrales (12,6%), las crisis psicógenas no epilépticas (3,6%) y el estado epiléptico (1,9%). Todos tenían descargas punta-onda generalizada en el electroencefalograma (EEG). El 19,2% presentó descargas asimétricas y el 28,2%, respuesta fotoparoxística. Observamos diferencias entre síndromes en politerapia (p < 0,0001), retirada de tratamiento (p = 0,01) y estar libres de crisis por encima de los 50 años (p = 0,004). Conclusiones. La EMJ fue la EGI más frecuente. Las crisis tonicoclónicas generalizadas fueron el tipo de crisis que presentaron más pacientes, seguidas de las mioclónicas, las ausencias y las crisis reflejas. El EEG mostró en más de una cuarta parte de los pacientes una respuesta fotoparoxística, y en uno de cada cinco, anomalías asimétricas. Se observaron diferencias según el síndrome en politerapia, persistencia de crisis y retirada de tratamiento (AU)


Introduction. Idiopathic generalised epilepsies (IGE) are a set of electroclinical syndromes with different phenotypes. Our aim is to analyse those phenotypes in patients over 16 years of age. Patients and methods. We conducted a retrospective analysis of a series of patients with IGE. They were classified as childhood absence epilepsy (CAE), juvenile absence epilepsy (JAE), juvenile myoclonic epilepsy (JME), epilepsy with tonicclonic seizures only (TCSE), epilepsy with eyelid myoclonias and absences (EMA) and pure photogenic epilepsy (PE). Results. We included 308 patients, the majority females (56.8%), in our study. JME was the most prevalent (40.9%), followed by TCSE (30%), JAE (10%), EMA (8.7%), CAE (7.7%) and PE (1.6%). The types of seizures presented by the most patients were tonic-clonic (89.6%), myoclonic (45.4%), absence (31.4%), reflex seizures (13.3%), eyelid myoclonias (12.6%), non-epileptic psychogenic seizures (3.6%) and status epilepticus (1.9%). They all had generalised spike-and-wave discharges in the electroencephalogram (EEG). 19.2% presented asymmetrical discharges and 28.2% showed a photoparoxysmal response. We observed differences between syndromes in polytherapy (p < 0.0001), withdrawal of therapy (p = 0.01) and being seizure-free beyond the age of 50 (p = 0.004). Conclusions. JME was the most frequent. Generalised tonic-clonic seizures were the type of seizures presented by the most patients, followed by myoclonic, absent and reflex seizures. The EEG showed a photoparoxysmal response in over a quarter of the patients, and one in five displayed asymmetrical anomalies. Differences were observed according to the syndrome in polytherapy, persistence of seizures and withdrawal of treatment (AU)


Subject(s)
Humans , Epilepsy, Generalized/classification , Seizures/classification , Electroencephalography , Retrospective Studies , Myoclonic Epilepsy, Juvenile/classification , Epilepsy, Absence/classification , Epilepsy, Tonic-Clonic/classification , Anticonvulsants/therapeutic use
3.
Epileptic Disord ; 18(4): 391-398, 2016 Dec 01.
Article in English | MEDLINE | ID: mdl-27910806

ABSTRACT

To describe the semiological features in patients suffering with Epilepsia Partialis Continua (EPC), also referred as Kozhevnikov syndrome and their relationship with aetiology, duration, and prognosis, as well as recurrence during follow-up. We analysed consecutive EPC patients diagnosed and followed in our centre over a seven-and-a half year period. We collected demographic and clinical data, along with neuroimaging and EEG recordings. All patients were followed for more than six months. Patients were categorised with single body area or multiple body area involvement according to the body parts affected. Recurrence was defined as a second EPC episode after one week. We collected data from 27 adult patients; 70.4% were men, the mean age was 65.2 years old (range: 17-89 years), and 40.7% had previous epilepsy. EPC causes were structural in 85.1% (stroke being the most frequent; 44.4%), metabolic in 11.1%, and of unknown origin in 7.4%. A cortical lesion on neuroimaging was shown in 70.4%. Involvement of multiple body areas was reported in 55.6% of patients. The optimal cut-off period to predict death was nine days (with a sensitivity of 62.5% and specificity of 75%; p=0.039), and this group of patients exhibited more multiple body area involvement (88.9% vs 38.9%; p=0.04). During follow-up, patients with cortical lesions had more EPC relapses (p=0.037). The most frequent aetiology of EPC in our patients was stroke. Multiple body area involvement and duration were associated with mortality. Patients with cortical lesions had more EPC relapses during follow-up.


Subject(s)
Epilepsia Partialis Continua/etiology , Epilepsia Partialis Continua/physiopathology , Adolescent , Adult , Aged , Aged, 80 and over , Epilepsia Partialis Continua/mortality , Female , Follow-Up Studies , Humans , Male , Middle Aged , Prognosis , Spain , Young Adult
4.
Clin Neuropharmacol ; 39(6): 299-301, 2016.
Article in English | MEDLINE | ID: mdl-27438183

ABSTRACT

BACKGROUND: Valproic acid (VPA) is an effective treatment in juvenile myoclonic epilepsy (JME), but concerns on its use during pregnancy are remarkable. Levetiracetam (LEV) is approved as second-line therapy, and used as monotherapy in clinical practice. Our objective was to analyze the outcome of LEV and VPA in JME. MATERIALS AND METHODS: We analyzed patients with JME attending our epilepsy unit between 2010 and 2014, including all patients treated with LEV and/or VPA at some point of the disease course. The primary end point was drug retention rate in monotherapy after the final analysis. RESULTS: We identified 58 patients (62% women). All had myoclonic seizures, 86% had generalized tonic-clonic seizures (GTCS) before the diagnosis, and 9% also had absences. All had generalized spike and wave on the interictal electroencephalogram, and 86% of them also had generalized polyspike and wave discharges. In total, LEV monotherapy was maintained in 15 (65%) of 23 patients, and VPA was maintained in 37 (74%) of 50 patients (P = 0.062). In women younger than 35 years, LEV had a similar retention rate with VPA (P = 0.939). More VPA patients achieved seizure freedom during follow-up (P < 0.01), whereas LEV patients showed a trend toward higher myoclonic freedom (0.085). CONCLUSIONS: Levetiracetam showed lower retention rate than VPA, primarily due to poorer seizure control during long-term follow-up. More LEV patients achieved myoclonic seizure freedom than VPA patients. In women younger than 35 years, LEV and VPA had comparable retention rate; therefore, LEV could be a good option for women with JME with prominent myoclonic seizures.


Subject(s)
Anticonvulsants/therapeutic use , Myoclonic Epilepsy, Juvenile/drug therapy , Piracetam/analogs & derivatives , Valproic Acid/therapeutic use , Adolescent , Adult , Electroencephalography , Female , Humans , Levetiracetam , Male , Middle Aged , Piracetam/therapeutic use , Retrospective Studies , Treatment Outcome , Young Adult
5.
Rev Neurol ; 60(6): 257-62, 2015 Mar 16.
Article in Spanish | MEDLINE | ID: mdl-25760720

ABSTRACT

INTRODUCTION: Visual phenomena can be symptoms of epileptic seizures, although with an uncertain clinical meaning and relationship with the epileptogenic focus. AIMS: To describe the clinical implications of visual epileptic seizures according to their signs and symptoms in adults. PATIENTS AND METHODS: Data were collected consecutively over a period of one year from patients who reported visual signs and symptoms as the main manifestation of their seizures, and the visual symptoms are classified according to the characteristics of the description. RESULTS: The sample consisted of 78 patients, with a mean age of 43.5 years. Focal epilepsy accounted for 97% of the cases. Of the 63% that were symptomatic epilepsies, 57% were vascular. The visual seizures were, in 81.9% of cases, the aura prior to the seizure, and 17.9% were isolated visual seizures. The coexistence of visual seizures and other types of seizure was associated to pharmacoresistance (p = 0.021). The visual symptoms reported were as follows: simple hallucinations (55.1%), illusions (23.1%), complex hallucinations (15.4%) and loss of vision (6.4%). The lobar localisation of the lesions was occipital (24.4%), temporoparietooccipital (21.8%), temporal (9%), parietal (3.8%) and frontal (1.3%). Occipital lesions were associated with simple visual hallucinations (p < 0.001), and visual illusions and complex visual hallucinations, with lesions affecting the temporoparietooccipital junction (p < 0.05). Of the 55.1% of patients with a unilateral lesion in the magnetic resonance scan, 33% reported symptoms in the contralateral visual hemifield. CONCLUSIONS: Visual seizures mainly present as epileptic auras. Simple hallucinations are related with an occipital origin, whereas complex hallucinations are associated with more anterior regions of the brain. The appearance of lateralised visual phenomena suggests an origin located in the contralateral hemisphere.


TITLE: Crisis epilepticas visuales. Semiologia e implicaciones clinicas.Introduccion. Los fenomenos visuales pueden ser sintomas de crisis epilepticas, aunque con un significado clinico y una relacion con el foco epileptogeno incierto. Objetivo. Describir las implicaciones clinicas de las crisis epilepticas visuales segun su semiologia en adultos. Pacientes y metodos. Durante un año se recoge consecutivamente a pacientes que describian semiologia visual como manifestacion principal de sus crisis y se clasifican los sintomas visuales segun las caracteristicas de la descripcion. Resultados. Se incluye a 78 pacientes con una edad media de 43,5 años. El 97% de los casos eran epilepsias focales. Entre el 63% de las epilepsias sintomaticas, el 57% eran vasculares. Las crisis visuales eran, en un 81,9%, el aura previa a la crisis, y en un 17,9%, crisis visuales aisladas. La coexistencia de crisis visuales y otro tipo de crisis se asocio a farmacorresistencia (p = 0,021). Los sintomas visuales fueron: alucinaciones simples (55,1%), ilusiones (23,1%), alucinaciones complejas (15,4%) y perdida de vision (6,4%). La localizacion lobar de las lesiones era occipital (24,4%), temporoparietooccipital (21,8%), temporal (9%), parietal (3,8%) y frontal (1,3%). Las lesiones occipitales se asociaron con alucinaciones visuales simples (p < 0,001), y las ilusiones visuales y alucinaciones visuales complejas, con lesiones de la encrucijada temporoparietooccipital (p < 0,05). Del 55,1% de los pacientes con lesion unilateral en la resonancia magnetica, el 33% referia los sintomas en el hemicampo visual contralateral. Conclusiones. Las crisis visuales se presentan, principalmente, como auras epilepticas. Las alucinaciones simples se relacionan con el origen occipital, mientras que las alucinaciones complejas se asocian con regiones cerebrales mas anteriores. La aparicion de fenomenos visuales lateralizados nos orienta a un origen en el hemisferio contralateral.


Subject(s)
Seizures/diagnosis , Adolescent , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Retrospective Studies , Young Adult
6.
Rev. neurol. (Ed. impr.) ; 60(6): 257-262, 16 mar., 2015. tab, graf, ilus
Article in Spanish | IBECS | ID: ibc-134596

ABSTRACT

Introducción. Los fenómenos visuales pueden ser síntomas de crisis epilépticas, aunque con un significado clínico y una relación con el foco epileptógeno incierto. Objetivo. Describir las implicaciones clínicas de las crisis epilépticas visuales según su semiología en adultos. Pacientes y métodos. Durante un año se recoge consecutivamente a pacientes que describían semiología visual como manifestación principal de sus crisis y se clasifican los síntomas visuales según las características de la descripción. Resultados. Se incluye a 78 pacientes con una edad media de 43,5 años. El 97% de los casos eran epilepsias focales. Entre el 63% de las epilepsias sintomáticas, el 57% eran vasculares. Las crisis visuales eran, en un 81,9%, el aura previa a la crisis, y en un 17,9%, crisis visuales aisladas. La coexistencia de crisis visuales y otro tipo de crisis se asoció a farmacorresistencia (p = 0,021). Los síntomas visuales fueron: alucinaciones simples (55,1%), ilusiones (23,1%), alucinaciones complejas (15,4%) y pérdida de visión (6,4%). La localización lobar de las lesiones era occipital (24,4%), temporoparietooccipital (21,8%), temporal (9%), parietal (3,8%) y frontal (1,3%). Las lesiones occipitales se asociaron con alucinaciones visuales simples (p < 0,001), y las ilusiones visuales y alucinaciones visuales complejas, con lesiones de la encrucijada temporoparietooccipital (p < 0,05). Del 55,1% de los pacientes con lesión unilateral en la resonancia magnética, el 33% refería los síntomas en el hemicampo visual contralateral. Conclusiones. Las crisis visuales se presentan, principalmente, como auras epilépticas. Las alucinaciones simples se relacionan con el origen occipital, mientras que las alucinaciones complejas se asocian con regiones cerebrales más anteriores. La aparición de fenómenos visuales lateralizados nos orienta a un origen en el hemisferio contralateral (AU)


Introduction. Visual phenomena can be symptoms of epileptic seizures, although with an uncertain clinical meaning and relationship with the epileptogenic focus. Aims. To describe the clinical implications of visual epileptic seizures according to their signs and symptoms in adults. Patients and methods. Data were collected consecutively over a period of one year from patients who reported visual signs and symptoms as the main manifestation of their seizures, and the visual symptoms are classified according to the characteristics of the description. Results. The sample consisted of 78 patients, with a mean age of 43.5 years. Focal epilepsy accounted for 97% of the cases. Of the 63% that were symptomatic epilepsies, 57% were vascular. The visual seizures were, in 81.9% of cases, the aura prior to the seizure, and 17.9% were isolated visual seizures. The coexistence of visual seizures and other types of seizure was associated to pharmacoresistance (p = 0.021). The visual symptoms reported were as follows: simple hallucinations (55.1%), illusions (23.1%), complex hallucinations (15.4%) and loss of vision (6.4%). The lobar localisation of the lesions was occipital (24.4%), temporoparietooccipital (21.8%), temporal (9%), parietal (3.8%) and frontal (1.3%). Occipital lesions were associated with simple visual hallucinations (p < 0.001), and visual illusions and complex visual hallucinations, with lesions affecting the temporoparietooccipital junction (p < 0.05). Of the 55.1% of patients with a unilateral lesion in the magnetic resonance scan, 33% reported symptoms in the contralateral visual hemifield. Conclusions. Visual seizures mainly present as epileptic auras. Simple hallucinations are related with an occipital origin, whereas complex hallucinations are associated with more anterior regions of the brain. The appearance of lateralised visual phenomena suggests an origin located in the contralateral hemisphere (AU)


Subject(s)
Humans , Male , Female , Epilepsy/diagnosis , Epilepsy/metabolism , Pharmaceutical Preparations/administration & dosage , Vision Disorders/metabolism , Vision Disorders/pathology , Hallucinations/diagnosis , Epilepsy/genetics , Epilepsy/psychology , Pharmaceutical Preparations , Vision Disorders/psychology , Vision Disorders/therapy , Hallucinations/complications , Epidemiology, Descriptive
7.
Rev Neurol ; 58(4): 147-51, 2014 Feb 16.
Article in Spanish | MEDLINE | ID: mdl-24504876

ABSTRACT

INTRODUCTION: Malformations of cortical development (MCD) are an important cause of epilepsy, delayed psychomotor development or neurological deficits. AIM. To report on the long-term clinical course and differential characteristics of several groups of MCD in adults with epilepsy. PATIENTS AND METHODS: Our sample consisted of patients over 16 years of age with MCD confirmed by magnetic resonance imaging, and epilepsy. The characteristics of the epilepsy, presence of neurological deficits, intellectual disability, history of perinatal pathology and electroencephalogram recordings were analysed. The patients were classified into three groups (G) in accordance with the Barkovich classification. RESULTS: A total of 85 patients with MCD were identified from 2630 patients with epilepsy and 79 of them were finally included in the sample. Mean age: 37 years, 57% were females. Mean age at onset of the crises: 17.8 years, and 59.5% were medication resistant. The distribution of the cases according to the Barkovich classification was: G1 (alterations affecting neuronal proliferation): 59.5%; G2 (alterations affecting migration): 25.3%; and G3 (alterations affecting cortical organisation): 15.2%. Focal neurological deficit was observed in 19% and 34.2% had an intelligence quotient < 80. On analysing by groups, G3 was found to display a higher percentage of focal neurological and intelligence quotient deficits than G1 and G2 (p < 0.05). CONCLUSIONS: Patients with MCD in G3 are more likely to have neurological deficit, intellectual disability and better control over their crises than patients from G1 and G2, most of whom present refractory epilepsy.


TITLE: Malformaciones del desarrollo cortical en pacientes adultos con epilepsia: serie de 79 casos.Introduccion. Las malformaciones del desarrollo cortical (MDC) son una causa importante de epilepsia, retraso del desarrollo psicomotor o deficits neurologicos. Objetivo. Describir la evolucion clinica a largo plazo y las caracteristicas diferenciales de los distintos grupos de MDC en adultos con epilepsia. Pacientes y metodos. Pacientes mayores de 16 años con MDC confirmada por resonancia magnetica y epilepsia. Se analizaron las caracteristicas de la epilepsia, la presencia de deficits neurologicos, la discapacidad intelectual, los antecedentes de patologia perinatal y el electroencefalograma. Los pacientes se clasificaron en tres grupos (G) segun la clasificacion de Barkovich. Resultados. Se identificaron 85 pacientes con MDC de 2.630 pacientes con epilepsia, y se incluyeron 79 pacientes. Edad media: 37 años, el 57% mujeres. Edad media al inicio de las crisis: 17,8 años. El 59,5% era farmacorresistente. La distribucion de los casos segun la clasificacion de Barkovich fue: G1 (alteraciones de la proliferacion neuronal): 59,5%; G2 (alteraciones de la migracion): 25,3%; y G3 (alteraciones de la organizacion cortical): 15,2%. El 19% presentaba un deficit neurologico focal y el 34,2% tenia un cociente intelectual < 80. Al analizar por grupos, el G3 mostraba un mayor porcentaje de deficits neurologicos focales y discapacidad intelectual que el G1 y el G2 (p < 0,05). Conclusion. Los pacientes con MDC del G3 tienen mayor probabilidad de tener deficit neurologico, discapacidad intelectual y mejor control de las crisis que los pacientes del G1 y G2, que se manifiestan, predominantemente, con epilepsia farmacorresistente.


Subject(s)
Epilepsies, Partial/etiology , Malformations of Cortical Development/complications , Adolescent , Adult , Age of Onset , Aged , Anticonvulsants/therapeutic use , Drug Resistance , Electroencephalography , Epilepsies, Partial/drug therapy , Female , Humans , Male , Malformations of Cortical Development/epidemiology , Middle Aged , Young Adult
8.
Rev. neurol. (Ed. impr.) ; 58(4): 147-151, 16 feb., 2014. tab, graf, ilus
Article in Spanish | IBECS | ID: ibc-119386

ABSTRACT

Introducción. Las malformaciones del desarrollo cortical (MDC) son una causa importante de epilepsia, retraso del desarrollo psicomotor o déficits neurológicos. Objetivo. Describir la evolución clínica a largo plazo y las características diferenciales de los distintos grupos de MDC en adultos con epilepsia. Pacientes y métodos. Pacientes mayores de 16 años con MDC confirmada por resonancia magnética y epilepsia. Se analizaron las características de la epilepsia, la presencia de déficits neurológicos, la discapacidad intelectual, los antecedentes de patología perinatal y el electroencefalograma. Los pacientes se clasificaron en tres grupos (G) según la clasificación de Barkovich. Resultados. Se identificaron 85 pacientes con MDC de 2.630 pacientes con epilepsia, y se incluyeron 79 pacientes. Edad media: 37 años, el 57% mujeres. Edad media al inicio de las crisis: 17,8 años. El 59,5% era farmacorresistente. La distribución de los casos según la clasificación de Barkovich fue: G1 (alteraciones de la proliferación neuronal): 59,5%; G2 (alteraciones de la migración): 25,3%; y G3 (alteraciones de la organización cortical): 15,2%. El 19% presentaba un déficit neurológico focal y el 34,2% tenía un cociente intelectual < 80. Al analizar por grupos, el G3 mostraba un mayor porcentaje de déficits neurológicos focales y discapacidad intelectual que el G1 y el G2 (p < 0,05). Conclusión. Los pacientes con MDC del G3 tienen mayor probabilidad de tener déficit neurológico, discapacidad intelectual y mejor control de las crisis que los pacientes del G1 y G2, que se manifiestan, predominantemente, con epilepsia farmacorresistente (AU)


Introduction. Malformations of cortical development (MCD) are an important cause of epilepsy, delayed psychomotor development or neurological deficits. Aim. To report on the long-term clinical course and differential characteristics of several groups of MCD in adults with epilepsy. Patients and methods. Our sample consisted of patients over 16 years of age with MCD confirmed by magnetic resonance imaging, and epilepsy. The characteristics of the epilepsy, presence of neurological deficits, intellectual disability, history of perinatal pathology and electroencephalogram recordings were analysed. The patients were classified into three groups (G) in accordance with the Barkovich classification. Results. A total of 85 patients with MCD were identified from 2630 patients with epilepsy and 79 of them were finally included in the sample. Mean age: 37 years, 57% were females. Mean age at onset of the crises: 17.8 years, and 59.5% were medication resistant. The distribution of the cases according to the Barkovich classification was: G1 (alterations affecting neuronal proliferation): 59.5%; G2 (alterations affecting migration): 25.3%; and G3 (alterations affecting cortical organisation): 15.2%. Focal neurological deficit was observed in 19% and 34.2% had an intelligence quotient < 80. On analysing by groups, G3 was found to display a higher percentage of focal neurological and intelligence quotient deficits than G1 and G2 (p < 0.05). Conclusions. Patients with MCD in G3 are more likely to have neurological deficit, intellectual disability and better control over their crises than patients from G1 and G2, most of whom present refractory epilepsy (AU)


Subject(s)
Humans , Cerebral Cortex/abnormalities , Malformations of Cortical Development/diagnosis , Epilepsies, Partial/diagnosis , Magnetic Resonance Imaging , Drug Resistance , Anticonvulsants/therapeutic use
9.
Rev. neurol. (Ed. impr.) ; 57(7): 306-312, 1 oct., 2013. graf, tab
Article in Spanish | IBECS | ID: ibc-116291

ABSTRACT

Introducción. La etiología de la epilepsia es un determinante importante del tratamiento y el pronóstico. Los avances diagnósticos y terapéuticos hacen pensar que la distribución causal, el tratamiento y el pronóstico de la población con epilepsia se hayan podido ver modificados. Objetivo. Describir la distribución sindrómica, etiológica y el tratamiento farmacológico en los pacientes con epilepsia. Pacientes y métodos. Estudio descriptivo transversal de pacientes con epilepsia atendidos de manera consecutiva en la consulta de nuestra unidad de epilepsia. Se recogieron datos demográficos, de síndrome, etiología y tratamiento farmacológico en el momento de la inclusión. Se analizaron los datos de modo conjunto y por grupos de edad. Resultados. Se incluyeron 1.557 pacientes, el 54% varones. El 73% de la muestra tenía una epilepsia focal, que era secundaria a una lesión estructural en el 56%. Las epilepsias generalizadas representaron el 20%. El 5% fue inclasificable. Por edad, la etiología vascular predominaba en prácticamente todos los grupos y su prevalencia aumentaba en relación con la edad. Los fármacos antiepilépticos más utilizados fueron ácido valproico (29%), levetiracetam (27%) y carbamacepina (20%). El 70% de las epilepsias generalizadas y el 57% de las focales seguían tratamiento en monoterapia. Conclusiones. La prevalencia por grupos de edad fue similar a la descrita en países desarrollados aunque se observó una menor prevalencia de epilepsias criptogénicas. Más del 60% de los pacientes seguía monoterapia y el ácido valproico fue el más utilizado (AU)


Introduction. The aetiology of epilepsy is an important decisive factor in its treatment and prognosis. Diagnostic and therapeutic advances suggest that the causal distribution, treatment and prognosis of the population with epilepsy may have undergone some modification. Aim. To describe the distribution of syndromes, aetiology and pharmacological treatment in patients with epilepsy. Patients and methods. We conducted a cross-sectional descriptive study of patients with epilepsy who were treated consecutively in our epilepsy department. Demographic data were collected, together with information about syndromes, aetiology and pharmacological treatment at the time of eligibility. The data were analysed jointly and by age groups Results. Altogether 1,557 patients were included, 54% of them males. Seventy-three per cent of the sample had focal epilepsy, which was secondary to a structural lesion in 56% of patients. Generalised epilepsies accounted for 20%. Five per cent were unclassifiable. By ages, vascular causation predominated in practically all the groups and its prevalence increased with age. The most commonly used antiepileptic drugs were valproic acid (29%), levetiracetam (27%) and carbamazepine (20%). Seventy per cent of the generalised epilepsies and 57% of the focal ones were on monotherapy treatment. Conclusions. The prevalence by age groups was similar to that reported in developed countries, although a lower prevalence of cryptogenic epilepsies was observed. More than 60% of patients followed monotherapy and valproic acid was the most widely used (AU)


Subject(s)
Humans , Male , Female , Adolescent , Young Adult , Adult , Middle Aged , Aged , Aged, 80 and over , Epilepsy/drug therapy , Epilepsy/etiology , Cross-Sectional Studies , Anticonvulsants/therapeutic use , Age Distribution
10.
Rev Neurol ; 57(7): 306-12, 2013 Oct 01.
Article in Spanish | MEDLINE | ID: mdl-24052441

ABSTRACT

INTRODUCTION: The aetiology of epilepsy is an important decisive factor in its treatment and prognosis. Diagnostic and therapeutic advances suggest that the causal distribution, treatment and prognosis of the population with epilepsy may have undergone some modification. AIM: To describe the distribution of syndromes, aetiology and pharmacological treatment in patients with epilepsy. PATIENTS AND METHODS: We conducted a cross-sectional descriptive study of patients with epilepsy who were treated consecutively in our epilepsy department. Demographic data were collected, together with information about syndromes, aetiology and pharmacological treatment at the time of eligibility. The data were analysed jointly and by age groups. RESULTS: Altogether 1,557 patients were included, 54% of them males. Seventy-three per cent of the sample had focal epilepsy, which was secondary to a structural lesion in 56% of patients. Generalised epilepsies accounted for 20%. Five per cent were unclassifiable. By ages, vascular causation predominated in practically all the groups and its prevalence increased with age. The most commonly used antiepileptic drugs were valproic acid (29%), levetiracetam (27%) and carbamazepine (20%). Seventy per cent of the generalised epilepsies and 57% of the focal ones were on monotherapy treatment. CONCLUSIONS: The prevalence by age groups was similar to that reported in developed countries, although a lower prevalence of cryptogenic epilepsies was observed. More than 60% of patients followed monotherapy and valproic acid was the most widely used.


TITLE: Etiologia y tratamiento de la epilepsia en una serie de 1.557 pacientes.Introduccion. La etiologia de la epilepsia es un determinante importante del tratamiento y el pronostico. Los avances diagnosticos y terapeuticos hacen pensar que la distribucion causal, el tratamiento y el pronostico de la poblacion con epilepsia se hayan podido ver modificados. Objetivo. Describir la distribucion sindromica, etiologica y el tratamiento farmacologico en los pacientes con epilepsia. Pacientes y metodos. Estudio descriptivo transversal de pacientes con epilepsia atendidos de manera consecutiva en la consulta de nuestra unidad de epilepsia. Se recogieron datos demograficos, de sindrome, etiologia y tratamiento farmacologico en el momento de la inclusion. Se analizaron los datos de modo conjunto y por grupos de edad. Resultados. Se incluyeron 1.557 pacientes, el 54% varones. El 73% de la muestra tenia una epilepsia focal, que era secundaria a una lesion estructural en el 56%. Las epilepsias generalizadas representaron el 20%. El 5% fue inclasificable. Por edad, la etiologia vascular predominaba en practicamente todos los grupos y su prevalencia aumentaba en relacion con la edad. Los farmacos antiepilepticos mas utilizados fueron acido valproico (29%), levetiracetam (27%) y carbamacepina (20%). El 70% de las epilepsias generalizadas y el 57% de las focales seguian tratamiento en monoterapia. Conclusiones. La prevalencia por grupos de edad fue similar a la descrita en paises desarrollados aunque se observo una menor prevalencia de epilepsias criptogenicas. Mas del 60% de los pacientes seguia monoterapia y el acido valproico fue el mas utilizado.


Subject(s)
Epilepsy/epidemiology , Adolescent , Adult , Age Distribution , Aged , Aged, 80 and over , Anticonvulsants/therapeutic use , Brain Injuries/complications , Brain Neoplasms/complications , Cross-Sectional Studies , Encephalitis/complications , Epilepsies, Partial/drug therapy , Epilepsies, Partial/epidemiology , Epilepsies, Partial/etiology , Epilepsy/classification , Epilepsy/drug therapy , Epilepsy/etiology , Epilepsy, Generalized/drug therapy , Epilepsy, Generalized/epidemiology , Epilepsy, Generalized/etiology , Female , Hemangioma, Cavernous, Central Nervous System/complications , Hospitals, University , Humans , Hypoxia, Brain/complications , Intracranial Arteriovenous Malformations/complications , Male , Meningeal Neoplasms/complications , Middle Aged , Spain/epidemiology , Stroke/complications , Tuberous Sclerosis/complications , Young Adult
11.
Rev Neurol ; 50(5): 279-82, 2010 Mar 01.
Article in Spanish | MEDLINE | ID: mdl-20217646

ABSTRACT

INTRODUCTION: Cerebral amyloid angiopathy is a frequent cause of haemorrhagic cerebrovascular disease in persons over the age of 65 and, sometimes, the initial symptoms can be epilepsy-like. CASE REPORT: A 62-year-old female with no relevant past history who was admitted to hospital due to non-convulsive status epilepticus, auditory hallucinations and ideomotor apraxia; an electroencephalogram performed on the patient revealed periodic lateralised epileptiform discharges in the right parietooccipital region. Susceptibility-weighted magnetic resonance imaging showed a sub-acute focal subarachnoid haemorrhage in the right parietotemporal region and cortico-subcortical microbleeding in different stages of the progression of the disease that were compatible with cerebral amyloid angiopathy. A critical simple single-photon emission tomography scan was performed and findings revealed an area of hyperperfusion in the same region. Antiepileptic treatment was established with clinical, neurophysiological and scintigraphic resolution. CONCLUSIONS: The article reports a case with non-convulsive status epilepticus as the initial symptom of cerebral amyloid angiopathy. It also highlights the usefulness of sequences of susceptibility-weighted magnetic resonance imaging and the physiopathogenesis of periodic lateralised epileptiform discharges as an element of epileptic activity is discussed.


Subject(s)
Cerebral Amyloid Angiopathy/complications , Status Epilepticus/etiology , Subarachnoid Hemorrhage/complications , Subarachnoid Hemorrhage/etiology , Aged , Aged, 80 and over , Anticonvulsants/therapeutic use , Cerebral Amyloid Angiopathy/diagnostic imaging , Cerebral Amyloid Angiopathy/pathology , Electroencephalography , Female , Humans , Magnetic Resonance Imaging , Middle Aged , Status Epilepticus/diagnostic imaging , Status Epilepticus/drug therapy , Status Epilepticus/pathology , Subarachnoid Hemorrhage/diagnostic imaging , Subarachnoid Hemorrhage/pathology , Tomography, X-Ray Computed
12.
Rev. neurol. (Ed. impr.) ; 50(5): 279-282, 1 mar., 2010. ilus
Article in Spanish | IBECS | ID: ibc-86805

ABSTRACT

Introducción. La angiopatía amiloide cerebral es una causa frecuente de enfermedad cerebrovascular hemorrágica en mayores de 65 años y, en ocasiones, la sintomatología inicial puede ser de tipo epiléptico. Caso clínico. Mujer de 62 años de edad sin antecedentes de interés que ingresa por estado de mal no convulsivo con sintomatología de desconexión del medio, alucinaciones auditivas y apraxia ideomotora, con aparición de descargas periódicas lateralizadas epileptiformes en la región parietooccipital derecha en el electroencefalograma. La resonancia con secuencia de susceptibilidad magnética mostró una hemorragia subaracnoidea focal subaguda en la región parietotemporal derecha y microsangrados corticosubcorticales en distintos estadios evolutivos compatibles con angiopatía amiloide cerebral. Se realizó una tomografía computarizada por emisión de fotón único crítica que mostró una área de hiperperfusión en la misma región. Se inició tratamiento antiepiléptico con resolución clínica, neurofisiológica y gammagráfica. Conclusión. Se presenta un caso clínico con estado de mal no convulsivo como manifestación inicial de angiopatía amiloide cerebral, se señala la utilidad de las secuencias de susceptibilidad magnética de la resonancia y se discute la fisiopatogenia de las descargas periódicas lateralizadas epileptiformes como elemento de actividad epiléptica (AU)


Introduction. Cerebral amyloid angiopathy is a frequent cause of haemorrhagic cerebrovascular disease in persons over the age of 65 and, sometimes, the initial symptoms can be epilepsy-like. Case report. A 62-year-old female with no relevant past history who was admitted to hospital due to non-convulsive status epilepticus, auditory hallucinations and ideomotor apraxia; an electroencephalogram performed on the patient revealed periodic lateralised epileptiform discharges in the right parietooccipital region. Susceptibility-weighted magnetic resonance imaging showed a sub-acute focal subarachnoid haemorrhage in the right parietotemporal region and cortico-subcortical microbleeding in different stages of the progression of the disease that were compatible with cerebral amyloid angiopathy. A critical simple single-photon emission tomography scan was performed and findings revealed an area of hyperperfusion in the same region. Antiepileptic treatment was established with clinical, neurophysiological and scintigraphic resolution. Conclusions. The article reports a case with non-convulsive status epilepticus as the initial symptom of cerebral amyloid angiopathy. It also highlights the usefulness of sequences of susceptibility-weighted magnetic resonance imaging and the physiopathogenesis of periodic lateralised epileptiform discharges as an element of epileptic activity is discussed (AU)


Subject(s)
Humans , Female , Middle Aged , Cerebral Amyloid Angiopathy/diagnosis , Epilepsy, Absence/etiology , Subarachnoid Hemorrhage/complications , Magnetic Resonance Imaging , Tomography, Emission-Computed, Single-Photon
SELECTION OF CITATIONS
SEARCH DETAIL
...